Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
05/25/2023 | Rani Therapeutics Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 101.3k | $4.11 | $416.2k | | 05/25/2023 |
05/18/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 3.5k | $189.87 | $655.8k | | 05/18/2023 |
02/23/2023 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Restricted Stock Units | 136 | $0.00 | $0 | | 02/23/2023 |
11/21/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 11.2k | $71.99 | $809.9k | | 11/21/2022 |
11/21/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 11.2k | $70.20 | $789.8k | | 11/21/2022 |
11/21/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 22.5k | $220.00 | $5M | | 11/21/2022 |
06/22/2022 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 35k | $3.22 | $112.7k | | 06/22/2022 |
05/25/2022 | Rani Therapeutics Holdings, Inc. | | Grant | Stock Option (Right to Buy) | 41.4k | $10.89 | $451k | | 05/25/2022 |
05/18/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 5.2k | $128.31 | $661.2k | | 05/18/2022 |
02/23/2022 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Restricted Stock Units | 136 | $0.00 | $0 | | 02/23/2022 |
07/15/2021 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4k | $171.95 | $693.3k | | 07/15/2021 |
06/16/2021 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 23k | $19.74 | $454k | | 06/16/2021 |
07/01/2020 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 4.6k | $148.77 | $681.5k | | 07/01/2020 |
06/18/2020 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 30k | $4.40 | $132k | | 06/18/2020 |
07/01/2019 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 9k | $72.01 | $648.1k | | 07/01/2019 |
06/13/2019 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 15k | $2.83 | $42.4k | | 06/13/2019 |
06/26/2018 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 15k | $9.09 | $136.4k | | 06/26/2018 |
06/20/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 9k | $105.26 | $947.3k | | 06/20/2018 |
04/26/2018 | PFIZER INC | PFE | Grant | Phantom Stock Units | 5.2k | $36.85 | $192.5k | | 04/26/2018 |
03/13/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 2.1k | $63.86 | $135.2k | | 03/13/2018 |
03/13/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 15k | $59.25 | $888.8k | | 03/13/2018 |
03/13/2018 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 17.1k | $150.00 | $2.6M | | 03/13/2018 |
11/02/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Sale | Common Stock | 20k | $130.00 | $2.6M | | 11/02/2017 |
11/02/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Exercise | Stock Option (right to buy) | 20k | $30.09 | $601.8k | | 11/02/2017 |
06/20/2017 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 15k | $11.21 | $168.2k | | 06/20/2017 |
06/02/2017 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 11.2k | $71.99 | $809.9k | | 06/02/2017 |
06/15/2016 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 15k | $30.24 | $453.6k | | 06/15/2016 |
06/03/2016 | ALNYLAM PHARMACEUTICALS, INC. | ALNY | Grant | Stock Option (right to buy) | 11.2k | $70.20 | $789.8k | | 06/03/2016 |
04/22/2010 | PFIZER INC | PFE | Grant | Phantom Stock Units | 0 | $0.00 | $0 | | 04/22/2010 |